- Acquired by Aptar Pharma, Oct 2024
About
SipNose focuses on nose-to-brain medical applications and is developing a nasal delivery platform for local, systemic, and central nervous system indications. The company’s intranasal drug-delivery platform uses a mechanism designed to improve efficacy, patient compliance, and safety.
SipNose’s noninvasive devices are designed to ensure accurate dose delivery via the nasal cavity and incorporate a simple, efficient mechanism to allow localization of the aerosolized drug in the olfactory epithelium, resulting in better absorption into the olfactory bulb and brain.
The company’s technology enables drug molecules of vast chemical and pharmaceutical characteristics to reach the brain faster and more efficiently with higher safety and improved patient experience.
Q&A
- What is SipNose's primary focus?
- SipNose focuses on nose-to-brain medical applications, developing an intranasal drug-delivery platform for local, systemic, and central nervous system indications.
- When was SipNose founded?
- SipNose was founded in November 2011.
- What is the current status of SipNose?
- SipNose was acquired by Aptar Pharma in October 2024.
- Where is SipNose headquartered?
- SipNose is headquartered in Yokne'am Illit, Israel.
- Who is a co-founder of SipNose?
- Daniel Shahaf is a co-founder and CTO of SipNose.
- What kind of technology does SipNose develop?
- SipNose develops noninvasive devices for accurate dose delivery via the nasal cavity, designed to localize aerosolized drugs in the olfactory epithelium for better absorption into the olfactory bulb and brain.
- Does SipNose hold any patents?
- Yes, SipNose holds one patent.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sipnose.com |
|---|---|
| linkedin.com/company/66605840 | |
| Wikidata | wikidata.org/wiki/Q30288681 |
Identifiers & details
| Founded | 2011-11 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Acquired by Aptar Pharma on Oct, 2024 |
| Wikidata QID | Q30288681 |
Acquisitions & public offerings
Acquired by Aptar Pharma 2024-10
Radar intelligence
Patents
| EPO | 21 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | sipnose.com |
|---|
Wikidata
| QID | Q30288681 |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|